Tag: Phoenix Bioscience Core
-

From Proven to Pioneering: SynCardia’s Next Leap in Artificial Heart Technology
Phoenix, AZ (November 12, 2025) – Tucson-based SynCardia Systems, LLC, the manufacturer of the SynCardia Total Artificial Heart, is a wholly owned subsidiary of Picard Medical, Inc. Picard Medical became a publicly traded company on August 29, 2025, and completed its Initial Public Offering (IPO) on September 2, 2025, raising approximately $19.5 million in gross…
-
Century of Discovery- 100 Years of VA Research
We are delighted to invite you to join us for the Phoenix and Northern Arizona VA Research Symposium, a premier event dedicated to showcasing the latest advancements and discoveries in research that benefit our veterans. Thursday, November 13th 12:00 pm – 4:00 pm In Person Biomedical Sciences Partnership Building
-

U of A Works to Build a Pediatric Powerhouse with Institute
Stewart Goldman, MD, left, and Vlad Kalinichenko, MD, PhD, right, are committed to improving the health and lives of children through their work with the Phoenix Children’s Research Institute, a collaborative effort between the University of Arizona College of Medicine – Phoenix and Phoenix Children’s hospital. (Photos by Noelle Haro-Gomez, U of A Health Sciences…
-

Improving life for children with autism
Northern Arizona University is playing a key role in a new nationwide research initiative funded by the National Institutes of Health to improve health and quality of life for people with autism. Olivia Lindly, an associate professor of health sciences in NAU’s Center for Community Health and Engaged Research (CHER), is co-principal investigator on a…
-

Faknostics — Redefining Cancer Therapeutics Through FAK Targeting
Phoenix, AZ (October 30, 2025) – According to the American Cancer Society, 2024 marked the first time the United States reported more than 2 million new cancer cases in a single year, with an estimated 2,001,140 diagnoses. This is where FAKnostics plans to make a difference by targeting focal adhesion kinase (FAK), a protein found…
-

Pioneering Early Detection for Ovarian Cancer
Phoenix, AZ (October 30, 2025) – A research team at the University of Arizona, led by Jennier Barton, PhD, who is currently serving as interim vice provost for health programs at UA Health Sciences, is redefining early detection in women’s health. The creation of the falloposcope could allow physicians to detect ovarian cancer at its…
-

GPN Vaccines Inc Completes Acquisition of BacVax Inc.
New York, USA – 24th October 2025 GPN Vaccines Inc (“GPN”) is pleased to announce it has successfully completed the acquisition of BacVax Inc. (“BacVax”), a biotechnology company based in Phoenix, Arizona, that is developing vaccines targeting bacterial infections. The acquisition further increases GPN’s footprint in the United States and builds the company’s pipeline through…
-
AZBio Trailblazers Awards
Join AZBio and members of the Arizona Business and Bioscience Community for a special luncheon to honor our Arizona Legislators and State and Local Elected Officials who have made it possible for the Arizona Bioscience Industry to gain national recognition, build capital infrastructure, and take its place as a leader in both scientific discovery and…







